Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History $34.25 -0.40 (-1.15%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$34.61 +0.36 (+1.05%) As of 09/4/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Crinetics Pharmaceuticals Stock Price Performance The Crinetics Pharmaceuticals (CRNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.82%, with a year-to-date return of -33.01%. In the past month, the stock has increased 17.13%, reflecting recent market activity. As of the latest close, Crinetics Pharmaceuticals traded at $34.25 with a market cap of $3.23 billion and volume of 1.32 million shares. Five years ago, the stock traded at $14.05, representing a 143.77% increase over that period. At the time, it had a market cap of $518.57 million and a volume of 115,487 shares. Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+10.52%1 Month Performance+17.13%3 Month Performance+5.97%Year-To-Date Performance-33.01%1 Year Performance-32.82%5 Year Performance+143.77% CRNX Stock Chart for Friday, September, 5, 2025 CRNX Chart by TradingView Crinetics Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/04/2025$34.65$34.25-1.15%$34.83$33.401.32 million shs$3.23 billion09/03/2025$33.30$34.65+4.05%$35.21$33.061.77 million shs$3.26 billion09/02/2025$30.99$33.30+7.45%$33.44$31.001.46 million shs$3.14 billion09/01/2025$30.99$30.99$31.22$30.251.14 million shs$2.92 billion08/29/2025$30.65$30.99+1.11%$31.22$30.251.14 million shs$2.92 billion08/28/2025$30.40$30.65+0.82%$31.45$30.27775,803 shs$2.89 billion08/27/2025$30.93$30.40-1.71%$31.16$30.24581,455 shs$2.86 billion08/26/2025$30.09$30.93+2.79%$31.07$30.00810,391 shs$2.91 billion08/25/2025$30.92$30.09-2.68%$31.36$29.91782,545 shs$2.83 billion08/22/2025$29.40$30.92+5.17%$31.70$29.631.36 million shs$2.91 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/21/2025$29.09$29.40+1.07%$29.89$28.731.55 million shs$2.77 billion08/20/2025$29.43$29.09-1.16%$29.64$28.94548,365 shs$2.74 billion08/19/2025$29.74$29.43-1.04%$30.45$29.31654,811 shs$2.77 billion08/18/2025$30.72$29.74-3.19%$31.17$29.72634,245 shs$2.80 billion08/15/2025$29.69$30.72+3.47%$30.85$29.831.00 million shs$2.89 billion08/14/2025$30.09$29.69-1.33%$29.88$29.17860,062 shs$2.80 billion08/13/2025$28.48$30.09+5.65%$30.29$28.62989,377 shs$2.83 billion08/12/2025$27.38$28.48+4.02%$28.66$27.52812,614 shs$2.68 billion08/11/2025$26.85$27.38+1.97%$27.76$26.501.17 million shs$2.58 billion08/08/2025$27.88$26.85-3.69%$28.10$25.832.00 million shs$2.51 billion08/07/2025$28.53$27.88-2.28%$28.97$27.191.07 million shs$2.61 billion08/06/2025$29.24$28.53-2.43%$29.18$27.721.21 million shs$2.67 billion08/05/2025$28.22$29.24+3.61%$29.93$27.651.65 million shs$2.74 billion08/04/2025$27.84$28.22+1.36%$28.39$27.601.01 million shs$2.64 billion Related Companies QIAGEN Stock Chart Moderna Stock Chart BridgeBio Pharma Stock Chart Elanco Animal Health Stock Chart Verona Pharma PLC American Depositary Share Stock Chart Roivant Sciences Stock Chart Grifols Stock Chart Revolution Medicines Stock Chart Rhythm Pharmaceuticals Stock Chart Legend Biotech Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRNX Stock Alerts